FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...
Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
The new drug type targets pathways in the peripheral nervous system before pain signals reach the brain, potentially lowering ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...
Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,818.20 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...